2020
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Neurology
鈥�Treats Adults
Michael T Pulley, MD, PhD
Neurologist, Clinical Neurophysiologist, Neuromuscular Medicine Physician
Michael T Pulley, MD, PhD
(904) 383-1022
Request appointment online
Research at a glance
Top areas of exploration
- Myasthenia Gravis , 8 publications
- Amyotrophic Lateral Sclerosis , 5 publications
- Prednisone , 5 publications
- Receptors, Cholinergic , 4 publications
Research activity
My publications
Filter publications
21 publications
2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
JAMA neurology
鈥�2019
Statin-associated muscle symptoms: Does the benefit outweigh the risk factor?
Muscle & nerve
鈥�2019
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.
Muscle & nerve
鈥�2019
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
The Lancet. Neurology
鈥�